China Is Filing Your Patents Back Home

The Acquisition That Keeps Giving, Just Not to You

Here is the scenario. A Chinese state-owned enterprise acquires a promising, R&D-intensive company in Germany or Ohio. It injects capital. It raises R&D spending. On paper, it looks like a vote of confidence in the host economy. Then the patents start filing, in Beijing.

That is the core finding of a major new study covered in this week's episode, and it reframes the entire conversation about Chinese foreign direct investment. The research team built a micro-level dataset spanning more than 161,000 companies across 159 countries, tracing capital ownership through geographies and, critically, through the tax havens that typically render these flows invisible to regulators.

The picture that emerges is not just large. It is structurally different from what standard FDI measures have been capturing.

The Numbers Are Staggering, and Already Dated

Start with the scale. Chinese outward investment has grown at roughly 20% per year. When flows from Hong Kong and Macau are included, the total reaches approximately $3.3 trillion globally, and that figure covers only through 2021. Given the pace of growth, the current number is almost certainly substantially higher.

The geographic concentration is pointed: 80% of that investment sits in advanced economies, primarily North America and Europe. The sectoral focus is equally deliberate. Manufacturing leads at $393 billion, followed by professional and scientific activities at $260 billion. These are not passive, yield-seeking capital placements. They are strategic positions in high-knowledge industries.

Then there is the routing. More than 37% of the firms in the dataset involve at least one intermediary domiciled in a tax haven. Around $800 billion in Chinese ownership has passed through the Cayman Islands, which now accounts for more than half of the Cayman Islands' non-financial assets. The researchers make the point plainly: conventional FDI measurement is structurally insufficient to capture what is actually happening.

Innovation Spillback: The Mechanism That Changes Everything

The most consequential finding is what the researchers call innovation spillback. After a Chinese acquirer, particularly an SOE, takes a position in a target firm, capital stock rises by about 7.3% and R&D expenditure rises by 6.6%. Both sound like good news for the acquired company and its home country.

They are not. Return on assets at the target firms is poor, sometimes negative. More importantly, the intellectual property generated after acquisition is not being registered by the target firm. It is being filed by the Chinese parent. The downstream value of the innovation, the patents, the licensing potential, the competitive advantage, flows back to China. The host country keeps the employment, perhaps, but not the upside.

The episode flags an additional layer of damage: crowding out. In sectors with heavy Chinese SOE presence, non-target peer firms reduce their own R&D investment. The effect is not contained to the acquired company. It degrades the broader innovation ecosystem.

Made in China 2025, and What Comes Next

The researchers tie this behavior explicitly to the Made in China 2025 initiative, which directed Chinese firms and SOEs to acquire foreign technology systematically, and to do so in ways that would not be immediately visible to host-country regulators. The strategy appears to have worked. Chinese parent firms show a sharp acceleration in granted patents following their first acquisition in a developed economy.

China has now released its 15th five-year plan. The episode raises the obvious question: why would a strategy this effective be abandoned?

The Regulatory Gap Is the Point

This study matters beyond the patent figures because it exposes a structural blind spot. Governments in the US and Europe have been assessing foreign investment risk using data that, by design, cannot trace ownership through tax havens and multi-layer intermediaries. The Cayman Islands figure alone suggests the gap between reported and actual Chinese investment exposure is enormous.

The episode connects this to adjacent problems: Section 301 trade investigations, the rerouting of Chinese-made goods through Vietnam and Mexico, and the separate issue of fake LLCs evading import duties. All of these threads run back to the same underlying question of who actually owns what.

For policymakers in Washington and Brussels, the study is less a warning shot than a delayed damage report. The more pressing task is deciding what enforcement and screening tools are adequate for a capital environment where ownership is deliberately obscured, and where the investment itself is designed to look constructive right up until the patents disappear.